SANGUINE CORP. (SGNC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: dwlima who wrote (2845)	7/8/1998 9:21:00 PM
From: drdan	Read Replies (2) of 5402

This one has little interest now because most people in the investment community don't have the medical background to appreciate products such as these...so they wait for black- and -white test data and they go nuts on the stock if the data is positive....take Entremed for example. The drug angiotensin is a constrictor of blood vessels and has been known for years.Angiostatin prevents blood vessel formation. So, the two drugs together basically strangle tumor blood vessels and without nutrients the tumor shrinks.....it's that simple.But people did not realize how simple yet brilliant the concept was,so there was little interest. When the data came out,everyone saw how brilliant the concept and execution was, and everyone fell over each other to buy the remarkable company's stock...so until investors SEE convincing data, they look, they shrug and they walk away, not knowing what the heck this thing is...

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next